The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Berkeley, CA

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Uma Suryadevara is a Hematologist in Berkeley, California. Dr. Suryadevara is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Bone Marrow Aspiration. Dr. Suryadevara is currently accepting new patients.

Kevin Knopf is an Oncologist in Berkeley, California. Dr. Knopf is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Colorectal Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Knopf is currently accepting new patients.

Chih-hsin Wen is a Urologist in Oakland, California. Dr. Wen is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urinary Tract Infection in Children, Reconstructive Urology Surgery, and Prostatectomy.

Wendy Patton is a Radiologist in Oakland, California. Dr. Patton is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Scrotal Swelling, Aseptic and Alopecic Nodules of Scalp (AANS), Progressive Familial Intrahepatic Cholestasis Type 2, and Progressive Familial Intrahepatic Cholestasis Type 1.

Charles Fiske is a Radiologist in Oakland, California. Dr. Fiske is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Breast Lump, Lung Nodules, Carbuncle, and Visceromegaly.

Dr. Derek Sun is a radiologist who interprets medical imaging that includes X-rays, ultrasound images, CT scans and MRI. He has a particular interest in diseases and conditions of the abdomen and pelvis. Sun earned his medical degree at Albert Einstein College of Medicine. He completed a residency in radiology at NYC Health + Hospitals/Jacobi, followed by a fellowship in abdominal imaging at UCSF. Sun is passionate about educating physicians-in-training. He serves as associate director of UCSF’s program in abdominal imaging and ultrasound, for which he teaches high-level concepts in medical imaging. He received the Hideyo Minagi Outstanding Teacher Award in 2019. A native San Franciscan, Sun enjoys giving back to his community. He volunteers at a local food bank and promotes STEM education (science, technology, engineering and mathematics) to Bay Area students. Dr. Sun is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Chronic Cough, Fibrolamellar Carcinoma, WT1-Related Wilms Tumor Syndromes, Progressive Familial Intrahepatic Cholestasis Type 1, and Small Bowel Resection.

Dr. Spencer Behr is a radiologist with expertise in molecular imaging, radiation therapy and abdominal imaging. He has a special interest in radiomics, extracting data from medical images that can be used to better predict and assess a patient's response to cancer treatment. Behr pursues translational research – applying laboratory findings to the development of medical therapies – on the use of molecular and hybrid imaging to better treat prostate cancer. He is particularly interested in new radiology techniques that combine PET scanning with CT or MRI. He has pursued research projects that involve collaboration among multiple departments, aiming to foster discussions among specialists of various disciplines and to optimize the impact of these studies on patient care. Behr earned his medical degree from Tufts University School of Medicine. He completed a residency in diagnostic radiology at Lahey Hospital & Medical Center, serving as chief resident. At UCSF, he completed fellowships in abdominal imaging and nuclear medicine. Behr enjoys mentoring medical students, residents and fellows, and has received national recognition for his excellence in teaching and mentoring. He serves as fellowship director for radiology and biomedical imaging, co-director of the Helen Diller Family Comprehensive Cancer Center's Cancer Imaging Research Shared Resource and vice chair of UCSF's Committee on Rules & Jurisdiction. Dr. Behr is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Neuroendocrine Tumor, Ureterocele, WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Prostatectomy.

Dr. Arpita Desai is a medical oncologist who specializes in caring for patients with genitourinary cancers (cancers of the genital or urinary organs). She particularly focuses on kidney and prostate cancers. She serves as medical director of the genitourinary medical oncology program at UCSF, where she leads efforts to deliver multidisciplinary, patient-centered care and advance innovative treatments. She also leads the UCSF kidney cancer program, which brings together clinical care, translational research and innovation to improve outcomes for patients with renal cell carcinoma. She also serves as medical director of the UCSF Von Hippel–Lindau multidisciplinary clinic, which integrates oncology, genetics, nephrology, ophthalmology, neurosurgery, endocrinology and other specialties to provide comprehensive, coordinated care for patients with Von-Hippel Lindau disease (a rare genetic disorder that increases a patient's risk of tumors). Through her leadership, research and national collaborations, Desai is committed to advancing precision medicine in kidney cancer and improving the lives of patients through both cutting-edge clinical care and translational research (lab findings that can lead to improvements in real-world patient care). In research, Desai is interested in developing novel imaging and treatment strategies for renal cell carcinoma, the most common type of kidney cancer. She is particularly interested in integrating functional and molecular imaging to personalize treatment and improve patient outcomes. Her research program examines theranostics, hyperpolarized MRI and biomarker-driven approaches to optimize treatments for genitourinary cancers. Desai earned her medical degree at Rajiv Gandhi University of Health Sciences in India. She completed a residency in internal medicine at the State University of New York at Buffalo, where she served as chief resident. She completed a fellowship in medical oncology at the University of Chicago. Desai is an active member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research and the National Comprehensive Cancer Network (NCCN) Kidney Cancer Guidelines Panel. She has received a Cancer Research Institute Investigator’s Technology Impact Award, Conquer Cancer Foundation of ASCO Merit Award and Dexter S. Levy, MD, Memorial Award for her commitment to teaching and excellence in patient care and has also been recognized with several awards for her mentorship and research. Dr. Desai is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Clear Cell Sarcoma, and Wilms Tumor.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy.

Dr. Benjamin M. Yeh is a radiologist who specializes in abdominal imaging. He has particular expertise in computed tomography (CT), contrast materials (substances introduced to make certain internal structures more visible), advanced liver imaging, and imaging of the genital and urinary organs. Yeh has received grants from the National Institutes of Health to study and develop novel CT contrast materials. He holds three patents. Yeh earned his medical degree at Duke University. He completed a residency in radiology and a fellowship in abdominal imaging at UCSF. Yeh is active in teaching at UCSF. Dr. Yeh is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Progressive Familial Intrahepatic Cholestasis Type 2, Progressive Familial Intrahepatic Cholestasis Type 1, WT1-Related Wilms Tumor Syndromes, Small Bowel Resection, and Liver Embolization.

Dr. Zhen Jane Wang is a radiologist who specializes in abdominal imaging. In research, Wang's interests focus on identifying novel imaging techniques and developing them into practical, useful diagnostic tools. Her research program includes using hyperpolarized 13C metabolic MRI – an advanced imaging technique – to assess kidney tumors' aggressiveness and diffuse kidney disease. She is also interested in quantitative imaging – a technique for measuring features of a tumor by applying algorithms to images – for assessing patients with pancreatic cancer. Wang has received research grants from private and public organizations, including the Society of Abdominal Radiology, Radiological Society of North America, U.S. Department of Defense and National Institutes of Health. In 2019, she received the Distinguished Investigator Award from the Academy for Radiology and Biomedical Imaging Research. After earning a bachelor's degree in electrical engineering at Brown University, Wang earned her medical degree from Northwestern University Feinberg School of Medicine. She completed a residency in diagnostic radiology at UCSF, serving as chief resident. She also completed a fellowship in abdominal imaging at UCSF. She joined the UCSF faculty in 2008. Wang serves as associate director for UCSF's program in biomedical imaging for clinician-scientists and as associate chair for strategic planning in the UCSF Department of Radiology and Biomedical Imaging. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Spontaneous Coronary Artery Dissection (SCAD), Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Pancreaticoduodenectomy, and Percutaneous Coronary Intervention (PCI).

Dr. Akshiv Malhotra is a medical oncologist who cares for patients with cancer or blood disorders. His treatment expertise includes gastrointestinal cancers, lung cancer, prostate cancer, breast cancer, lymphoma, leukemia and multiple myeloma. In patient care, he prescribes medical treatments, such as chemotherapy, immunotherapy and targeted therapy, while also incorporating lifestyle changes to reduce stress and improve exercise habits, diet and sleep. Malhotra earned his medical degree at DY Patil University School of Medicine in India. He completed a residency in internal medicine at the State University of New York Upstate Medical University and a fellowship in hematology and oncology at the University of Cincinnati. Malhotra's research has focused on treatments for various cancers and blood disorders. He has published articles in multiple peer-reviewed journals and presented on these topics at several conferences. Malhotra is a member of the American Society of Clinical Oncology and American Society of Hematology. Malhotra spends his free time with his wife and two young daughters. They enjoy the outdoors, particularly traveling to, exploring and hiking in national parks. Malhotra's other interests include playing board games, listening to podcasts and audiobooks, watching cricket and working out at CrossFit Oakland. Dr. Malhotra is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Testicular Yolk Sac Tumor, and Ovarian Carcinosarcoma.

Daniel Oberlin is a Urologist in Berkeley, California. Dr. Oberlin is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Obstructive Uropathy, Asymptomatic Bacteriuria, Enlarged Prostate (BPH), Prostatectomy, and Vasectomy.

Catherine Jiam is a primary care provider, practicing in Family Medicine in Orinda, California. Dr. Jiam is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Chronic Polyradiculoneuritis, Miller-Fisher Syndrome, Guillain-Barre Syndrome, and Macroamylasemia.

Caring, compassionate, and patient centric care. Dr. Quock is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Dr. Robert Flavell is a radiologist who cares for both adults and children, and specializes in nuclear medicine, the use of small amounts of radioactive materials to evaluate organ systems. He is chief of molecular imaging and therapeutics for the UCSF Department of Radiology and Biomedical Imaging. In research, Flavell focuses on developing new methods of diagnosing and treating cancer using molecular imaging technology, which shows what is taking place in the body at a cellular and molecular level. After earning a doctorate in chemical biology at the Rockefeller University, Flavell earned his medical degree at Weill Cornell Medicine. At UCSF, he completed a residency in diagnostic radiology, followed by a fellowship in nuclear medicine. Dr. Flavell is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Neuroendocrine Tumor, Smoldering Multiple Myeloma, Fibrolamellar Carcinoma, and Gastrointestinal Stromal Tumor.

Dr. Javier Villanueva-Meyer is a neuroradiologist who specializes in brain tumor imaging. He is experienced in CT, MRI and X-ray imaging of the head and neck, brain, spine and peripheral nervous system. He also performs image-guided procedures to diagnose and treat conditions of the nervous system, with techniques including percutaneous biopsy (image-guided skin punctures to obtain samples for analysis), lumbar puncture, myelography (examining the spinal canal), cisternography (examining the fluid around the brain and spinal cord), epidural injection and selective nerve root injection. He has a special interest in improving the quality of care in the practice of radiology and biomedical imaging. Villanueva-Meyer's research focuses on the how best to use molecular imaging techniques for brain cancer patients. He works closely with colleagues in the UCSF Brain Tumor Center to evaluate emerging imaging and interpretation technologies. Villanueva-Meyer earned his medical degree from Baylor College of Medicine. At UCSF, he completed a residency in diagnostic radiology and a fellowship in neuroradiology. Also at UCSF, he completed a postdoctoral fellowship funded by the National Institutes of Health as part of a program that prepares doctors to conduct research in areas that will most serve the nation's needs. Dr. Villanueva is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Meningioma, Relapsing Multiple Sclerosis (RMS), Pediatric Low-Grade Glioma (pLGG), Craniectomy, and Orchiectomy.

Dr. Matthew Bucknor is a radiologist who diagnoses and treats diseases and injuries of the musculoskeletal system. Guided by imaging technologies including X-ray, ultrasound, CT and MRI, he performs procedures such as injections, tissue sampling and focal tumor treatments (a noninvasive technique for treating small tumors using energy sources). Bucknor's research focuses on developing magnetic resonance–guided focused ultrasound, a noninvasive method for treating tumors using sound waves. He oversees UCSF clinical trials that evaluate ways to use this technology for various conditions. Bucknor earned his medical degree from Stanford University School of Medicine. He completed a residency in radiology at UCSF and a fellowship in musculoskeletal imaging and intervention at Stanford. Honoring his commitment to promoting diversity, inclusion and health equity in medicine, UCSF named Bucknor a John A. Watson Faculty Scholar and awarded him the Chancellor Award for Dr. Martin Luther King Jr. Leadership. Dr. Bucknor is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Desmoid Tumor, Tenosynovitis, Melorheostosis, Melorheostosis with Osteopoikilosis, and Rhizotomy.

Liina Poder is a Radiologist in San Francisco, California. Dr. Poder is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Jaundice, Visceromegaly, WT1-Related Wilms Tumor Syndromes, and Placenta Previa. Dr. Poder is currently accepting new patients.